Office of Inspector Generals Compliance Program Guidance for Pharmaceutical Manufacturers
April 2003 Office of Inspector Generals Compliance Program Guidance for Pharmaceutical Manufacturers I. Introduction The Office of Inspector General (OIG) of the Department of Health and Human Services is continuing in its efforts to promote voluntary compliance programs for the health care industry. This compliance guidance is intended to assist companies that develop, manufacture, market, and sell pharmaceutical drugs or biological products (pharmaceutical manufacturers) in developing and implementing internal controls and procedures that promote adherence to applicable statutes, regulations, and requirements of the federal health care programs1 and in evaluating and, as necessary, refining existing compliance programs. This guidance provides . . .
